Epstein Secrets

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula E

kil Beshir Ulrich L. Bettermann Erik Behermann Jeffrey L. Bewkes Donald S. Beyer Homi K. Bhabha Neera

zerland University of Southampton United Kingdom The Dow Chemical Company USA Apex Partners LLP United Kingdom Viking Global Investors LP USA Kaiser Foundation Health Plan USA Inc. The University of Tokyo An-Nahar BASF SE Japan Lebanon Germany University of Oxford United Kingdom Global Green Growth Instit

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

oundation Canada Olivier Baube Editor-in-Chief, Economy Agence France Presse France (AFP) Raymond J. Baxter Senior Vice-President. Community Kaiser Foundation Health USA Benefit, Research and Health Policy Plan Inc. Eben Bayer Founder and Chief Executive Officer Ecovative Design LLC USA Alexander Bazarov

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

oundation Canada Olivier Baube Editor-in-Chief, Economy Agence France Presse France (AFP) Raymond J. Baxter Senior Vice-President. Community Kaiser Foundation Health USA Benefit, Research and Health Policy Plan Inc. Eben Bayer Founder and Chief Executive Officer Ecovative Design LLC USA Alexander Bazarov

John K. Defterios John J. DeGioia Alain Dehaze Jeffrey Deitch Marijn E. Dekkers Michael S. Dell Chris

ers Watson USA Camargo Correa SA Brazil The Dow Chemical Company Switzerland Apax Partners LLP United Kingdom Viking Global Investors LP USA Kaiser Foundation Health Plan USA Inc. The University of Tokyo An-Nahar Japan Lebanon The Coca-Cola Company USA University of Oxford Taconic Capital Advisors Embass